Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

FREE BLOG Is it ever worth running a hospital for a government?

The idea that the private sector, thanks to its efficiency and management skills, can build and run a public hospital, or manage an existing public hospital, is beguiling. It is also increasingly clear that it is a bird which never flies.

Interview: Stefan Larsson, Senior Partner, BCG

Worldwide, Stefan Larsson foresees a strong move in healthcare away from fee for service, in which quality is not measured and rewarded, to a system which measures and rewards outcomes. He thinks that model will apply across acute, elderly and chronic care. But how real is the shift? Here we talk to Larsson about examples of operators who have seen significant growth and about how payors are about to shift away from DRGs. He is a Co-founder of the International Consortium for Health Outcomes Measurement (ICHOM), a not-for-profit devoted to the development of global standards for measurement of health outcomes that matter to patients.

Alzira model looks doomed

The Alzira model looks doomed as Valencia cracks down on the private concessions which run healthcare for over 1m people. The newly elected left wing coalition government is hostile to the model and is carrying out rigorous audits which are likely to destroy profits. Two large insurers have already sold their stakes to Ribera Salud, which is 50% owned by US operator Centene. But there are still international opportunities for Alzira.

French private hospitals to sue public funding bodies

The association Fédération de l’Hospitalisation Privée (FHP-MCO) is encouraging private hospitals to sue France’s local public funding bodies, the Agences Régionales de Santé (ARSs), for their bias toward public hospitals in the allocation of funds. The approach seems to be working.

Hesira aims for Swiss consolidation

Pan-European dentistry chain, Hesira, is to buy Cliniques Dentaires de Genève (CDG), a Swiss high-end dentistry group of three clinics, through its existing Adent chain of 9 outlets, also in French-speaking Switzerland.

Report: Thailand: Asia’s Dark Horse

Nestled between the giant Indian, Chinese and Malaysian markets, Thailand has long passed under the radar. No more. Public health reform and aging populations have spurred rapid growth. And no longer content with medical tourists, its highly profitable hospital groups are moving abroad. Can these dark horses take advantage of the integration of ASEAN and become the dominant force in the region?

Myanmar groups fight back against medical tourism

It is estimated that Myanmar loses 100,000 patients and $200m a year to medical tourism, says Soe Myint, founder of the local Family Mandalar hospital group. Foreign groups such as Indonesia’s Siloam and Thailand’s Thonburi, have been drawn in. Siloam is investing $1bn in Myanmar over the next ten years. But local groups are fighting back.

Interview: Sudi Narasimhan, Corporate Director of Marketing and Business Development at Bumrungrad Hospital Group

Bumrungrad is a world leader in medical tourism and has effectively leveraged Thailand’s many advantages in this sector. Unlike its competitors, it has focused on high-end tertiary care from a single campus. Narasimhan leads us through the history of the group, the secret to profit margins of 20%, the changing dynamics of medical tourism and the future of the Thai market.

FREE BLOG An economy driven by healthcare or poor health driven by the economy?

In her opening address to the World Health Assembly last month, WHO Director-General, Dr Margaret Chan said: “This is a unique time in history where economic progress is actually increasing threats to health, instead of reducing them.” The statement suggests our current approach to economic and social progress is flawed and contributing to poor health. Not just poor health, in fact, but a global epidemic of non-communicable diseases.

Will China’s five year plan help private sector?

The latest five-year plan announced by the Chinese government aims to boost private sector involvement in the healthcare industry. This signals a major shift in government policy say market insiders, and will cheer operators and investors, domestically and abroad.

Find Us